IP Verse

Wyeth Llc patent opposition analysis

Latest patents of Wyeth Llc opposed by its competitors

The following table provides an overview of the latest patents of Wyeth Llc that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP2676679Aug 28, 2024Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions3
EP3246044Apr 10, 2024Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens1
EP3572073Dec 20, 2023Lyophilization Above Collapse1
EP3175853Nov 1, 2023Antineoplastic Combinations Of Neratinib And Capecitabine1
EP1942868Oct 4, 2023Sodium Chloride Solution For Drug Reconstitution Or Dilution1
EP3263571Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof1
EP3000467Mar 1, 2023Treatment Regimen Utilizing Neratinib For Breast Cancer3
EP2498756Feb 15, 2023Tablet Formulations Of Neratinib Maleate1
EP3255141Dec 1, 2021Production Of Antibodies With Improved Glycosylation Pattern2
EP3002009Jul 7, 2021Treatment Of Imatinib Resistant Leukemia Using 4-Aminoquinoline-3-Carbonitriles1

Top competitors of Wyeth Llc